标题
Chimeric antigen receptor T-cell therapy for HIV cure
作者
关键词
-
出版物
Current Opinion in HIV and AIDS
Volume Publish Ahead of Print, Issue -, Pages -
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2021-02-22
DOI
10.1097/coh.0000000000000665
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Broadly neutralizing antibodies for HIV-1: efficacies, challenges and opportunities
- (2020) Yubin Liu et al. Emerging Microbes & Infections
- The Biology of the HIV-1 Latent Reservoir and Implications for Cure Strategies
- (2020) Lillian B. Cohn et al. Cell Host & Microbe
- HIV-Resistant and HIV-Specific CAR-Modified CD4+ T Cells Mitigate HIV Disease Progression and Confer CD4+ T Cell Help In Vivo
- (2020) Colby R. Maldini et al. MOLECULAR THERAPY
- Engineering CAR T Cells to Target the HIV Reservoir
- (2020) Wenli Mu et al. Frontiers in Cellular and Infection Microbiology
- Dual CD4-based CAR T cells with distinct costimulatory domains mitigate HIV pathogenesis in vivo
- (2020) Colby R. Maldini et al. NATURE MEDICINE
- Broadly neutralizing plasma antibodies effective against autologous circulating viruses in infants with multivariant HIV-1 infection
- (2020) Nitesh Mishra et al. Nature Communications
- The Influence of Chimeric Antigen Receptor Structural Domains on Clinical Outcomes and Associated Toxicities
- (2020) Ashleigh S. Davey et al. Cancers
- An immunoproteomic approach to characterize the CAR interactome and signalosome
- (2019) Maria C. Ramello et al. Science Signaling
- HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation
- (2019) Ravindra K. Gupta et al. NATURE
- The HIV Reservoir in Monocytes and Macrophages
- (2019) Michelle E. Wong et al. Frontiers in Immunology
- Next-generation regulatory T cell therapy
- (2019) Leonardo M. R. Ferreira et al. NATURE REVIEWS DRUG DISCOVERY
- Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model
- (2019) Kim Anthony-Gonda et al. Science Translational Medicine
- Attacking Latent HIV with convertibleCAR-T Cells, a Highly Adaptable Killing Platform
- (2019) Eytan Herzig et al. CELL
- Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01
- (2019) Dora Pinto et al. Cell Host & Microbe
- Microglial Cells: The Main HIV-1 Reservoir in the Brain
- (2019) Clementine Wallet et al. Frontiers in Cellular and Infection Microbiology
- Common Features of Enveloped Viruses and Implications for Immunogen Design for Next-Generation Vaccines
- (2018) Felix A. Rey et al. CELL
- Bispecific chimeric antigen receptors targeting the CD4 binding site and high-mannose Glycans of gp120 optimized for anti–human immunodeficiency virus potency and breadth with minimal immunogenicity
- (2018) Mustafa H. Ghanem et al. CYTOTHERAPY
- In Vivo Expansion and Antitumor Activity of Coinfused CD28- and 4-1BB-Engineered CAR-T Cells in Patients with B Cell Leukemia
- (2018) Zhi Cheng et al. MOLECULAR THERAPY
- Characterization of broadly neutralizing antibody responses to HIV-1 in a cohort of long term non-progressors
- (2018) Nuria González et al. PLoS One
- What Is the most Important for Elite Control: Genetic Background of Patient, Genetic Background of Partner, both or neither? Description of Complete Natural History within a Couple of MSM
- (2018) M. Bendenoun et al. EBioMedicine
- Combination therapy with anti-HIV-1 antibodies maintains viral suppression
- (2018) Pilar Mendoza et al. NATURE
- Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function
- (2018) Alexander I. Salter et al. Science Signaling
- Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys
- (2018) Erica N. Borducchi et al. NATURE
- Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency
- (2018) Judith Feucht et al. NATURE MEDICINE
- Engineering HIV-Resistant, Anti-HIV Chimeric Antigen Receptor T Cells
- (2017) Malika Hale et al. MOLECULAR THERAPY
- Function of Novel Anti-CD19 Chimeric Antigen Receptors with Human Variable Regions Is Affected by Hinge and Transmembrane Domains
- (2017) Leah Alabanza et al. MOLECULAR THERAPY
- Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
- (2017) Justin Eyquem et al. NATURE
- Antibody 10-1074 suppresses viremia in HIV-1-infected individuals
- (2017) Marina Caskey et al. NATURE MEDICINE
- Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
- (2017) Sattva S. Neelapu et al. Nature Reviews Clinical Oncology
- Supraphysiologic control over HIV-1 replication mediated by CD8 T cells expressing a re-engineered CD4-based chimeric antigen receptor
- (2017) Rachel S. Leibman et al. PLoS Pathogens
- Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design
- (2016) Dennis R. Burton et al. Annual Review of Immunology
- Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4 + T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy
- (2016) Bingfeng Liu et al. JOURNAL OF VIROLOGY
- HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption
- (2016) Johannes F. Scheid et al. NATURE
- Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption
- (2016) Katharine J. Bar et al. NEW ENGLAND JOURNAL OF MEDICINE
- HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1
- (2016) T. Schoofs et al. SCIENCE
- Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo
- (2016) C.-L. Lu et al. SCIENCE
- Potent and Broad Inhibition of HIV-1 by a Peptide from the gp41 Heptad Repeat-2 Domain Conjugated to the CXCR4 Amino Terminus
- (2016) George J. Leslie et al. PLoS Pathogens
- The C34 Peptide Fusion Inhibitor Binds to the Six-Helix Bundle Core Domain of HIV-1 gp41 by Displacement of the C-Terminal Helical Repeat Region
- (2015) John M. Louis et al. BIOCHEMISTRY
- Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design
- (2015) Raiees Andrabi et al. IMMUNITY
- Novel CD4-Based Bispecific Chimeric Antigen Receptor Designed for Enhanced Anti-HIV Potency and Absence of HIV Entry Receptor Activity
- (2015) Li Liu et al. JOURNAL OF VIROLOGY
- Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells
- (2015) M. J. Frigault et al. Cancer Immunology Research
- Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
- (2014) Pablo Tebas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection
- (2013) C. A. Didigu et al. BLOOD
- Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission
- (2013) Marine Malbec et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Exceptionally Potent and Broadly Cross-Reactive, Bispecific Multivalent HIV-1 Inhibitors Based on Single Human CD4 and Antibody Domains
- (2013) W. Chen et al. JOURNAL OF VIROLOGY
- High-dimensional immunomonitoring models of HIV-1-specific CD8 T-cell responses accurately identify subjects achieving spontaneous viral control
- (2012) Z. M. Ndhlovu et al. BLOOD
- Safety and stability of retrovirally transduced chimeric antigen receptor T cells
- (2012) Christos Colovos et al. Immunotherapy
- Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells
- (2012) J. Scholler et al. Science Translational Medicine
- Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing
- (2011) X. Wu et al. SCIENCE
- Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
- (2011) J. F. Scheid et al. SCIENCE
- Engineering HIV-Resistant Human CD4+ T Cells with CXCR4-Specific Zinc-Finger Nucleases
- (2011) Craig B. Wilen et al. PLoS Pathogens
- Bifunctional fusion proteins of the human engineered antibody domain m36 with human soluble CD4 are potent inhibitors of diverse HIV-1 isolates
- (2010) Weizao Chen et al. ANTIVIRAL RESEARCH
- Antitransgene Rejection Responses Contribute to Attenuated Persistence of Adoptively Transferred CD20/CD19-Specific Chimeric Antigen Receptor Redirected T Cells in Humans
- (2010) Michael C. Jensen et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Evidence for the cure of HIV infection by CCR5 32/ 32 stem cell transplantation
- (2010) K. Allers et al. BLOOD
- The Optimal Antigen Response of Chimeric Antigen Receptors Harboring the CD3 Transmembrane Domain Is Dependent upon Incorporation of the Receptor into the Endogenous TCR/CD3 Complex
- (2010) J. S. Bridgeman et al. JOURNAL OF IMMUNOLOGY
- Transitions to and from the CD4-Bound Conformation Are Modulated by a Single-Residue Change in the Human Immunodeficiency Virus Type 1 gp120 Inner Domain
- (2009) A. Kassa et al. JOURNAL OF VIROLOGY
- Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo
- (2009) Michael C. Milone et al. MOLECULAR THERAPY
- Long-Term Control of HIV byCCR5Delta32/Delta32 Stem-Cell Transplantation
- (2009) Gero Hütter et al. NEW ENGLAND JOURNAL OF MEDICINE
- The biology of CCR5 and CXCR4
- (2009) Ghalib Alkhatib Current Opinion in HIV and AIDS
- Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases
- (2008) Elena E Perez et al. NATURE BIOTECHNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started